JP2007510622A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007510622A5 JP2007510622A5 JP2006534362A JP2006534362A JP2007510622A5 JP 2007510622 A5 JP2007510622 A5 JP 2007510622A5 JP 2006534362 A JP2006534362 A JP 2006534362A JP 2006534362 A JP2006534362 A JP 2006534362A JP 2007510622 A5 JP2007510622 A5 JP 2007510622A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- gene
- chain gene
- vie
- vib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50947303P | 2003-10-08 | 2003-10-08 | |
| PCT/US2004/033176 WO2005034733A2 (en) | 2003-10-08 | 2004-10-08 | Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007510622A JP2007510622A (ja) | 2007-04-26 |
| JP2007510622A5 true JP2007510622A5 (https=) | 2007-11-22 |
Family
ID=34434984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006534362A Pending JP2007510622A (ja) | 2003-10-08 | 2004-10-08 | Ｂ細胞慢性リンパ性白血病の診断及び治療のための方法及び組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8119340B2 (https=) |
| EP (1) | EP1678195A4 (https=) |
| JP (1) | JP2007510622A (https=) |
| AU (1) | AU2004279441B2 (https=) |
| CA (1) | CA2541360A1 (https=) |
| WO (1) | WO2005034733A2 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR045563A1 (es) | 2003-09-10 | 2005-11-02 | Warner Lambert Co | Anticuerpos dirigidos a m-csf |
| EP1678195A4 (en) | 2003-10-08 | 2008-04-23 | The Feinstein Inst Medical Res | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CHRONIC LYMPHOCYTIC B-CELL LEUKEMIA |
| US20070105165A1 (en) * | 2005-11-04 | 2007-05-10 | Charles Goolsby | Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers |
| US7767206B2 (en) * | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| TW200918553A (en) * | 2007-09-18 | 2009-05-01 | Amgen Inc | Human GM-CSF antigen binding proteins |
| AR072999A1 (es) | 2008-08-11 | 2010-10-06 | Medarex Inc | Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos |
| EP2576621B1 (en) * | 2010-05-27 | 2019-04-10 | Genmab A/S | Monoclonal antibodies against her2 |
| CA2800769C (en) | 2010-05-27 | 2021-11-02 | Genmab A/S | Monoclonal antibodies against her2 epitope |
| AU2011261396B2 (en) * | 2010-06-02 | 2015-11-05 | Dana-Farber Cancer Institute, Inc. | Humanized monoclonal antibodies and methods of use |
| AU2012245116A1 (en) | 2011-04-20 | 2013-11-07 | Genmab A/S | Bispecific antibodies against HER2 and CD3 |
| KR20220084444A (ko) | 2012-05-31 | 2022-06-21 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Pd-l1에 결합하는 항원 결합 단백질 |
| UY34887A (es) | 2012-07-02 | 2013-12-31 | Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware | Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos |
| DE102012212025A1 (de) * | 2012-07-10 | 2014-01-16 | Osram Gmbh | Leuchtmodul |
| EP2741084B1 (en) | 2012-12-07 | 2020-01-22 | AVA Lifescience GmbH | Method of prognosing the clinical course of chronic lymphocytic leukemia (CLL) |
| CA2936092A1 (en) | 2013-01-23 | 2014-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Stabilized hepatitis b core polypeptide |
| JP6595458B2 (ja) | 2013-09-20 | 2019-10-23 | ブリストル−マイヤーズ スクイブ カンパニー | 腫瘍を処置するための抗ｌａｇ−３抗体と抗ｐｄ−１抗体との組合せ |
| PE20170255A1 (es) | 2014-01-24 | 2017-03-22 | Dana Farber Cancer Inst Inc | Moleculas de anticuerpo que se unen a pd-1 y usos de las mismas |
| KR102442436B1 (ko) | 2014-03-14 | 2022-09-15 | 노파르티스 아게 | Lag-3에 대한 항체 분자 및 그의 용도 |
| EP3149167B1 (en) * | 2014-05-30 | 2019-09-04 | Academia Sinica | Aptamer targeting mage-a3 peptide and uses thereof |
| HRP20211058T8 (hr) | 2015-07-29 | 2021-11-26 | Novartis Ag | Kombinirane terapije koje sadrže molekule antitijela protiv lag-3 |
| EP3328994A4 (en) * | 2015-07-31 | 2019-04-17 | Memorial Sloan-Kettering Cancer Center | CD56-Faced Antigen-Binding Proteins and Uses Thereof |
| RU2018107056A (ru) * | 2015-08-24 | 2019-09-26 | МЕДИММЬЮН, ЭлЭлСи | Полипептиды mrka, антитела к ним и пути их применения |
| US10221249B2 (en) | 2015-09-10 | 2019-03-05 | Affigen, Llc | Method of making patient specific anti-idiotype antibodies |
| WO2018152452A1 (en) | 2017-02-17 | 2018-08-23 | Mapp Biopharmaceutical, Inc. | Monoclonal antibodies and cocktails for treatment of ebola infections |
| CN110678200B (zh) | 2017-05-30 | 2024-05-17 | 百时美施贵宝公司 | 包含抗lag-3抗体或抗lag-3抗体和抗pd-1或抗pd-l1抗体的组合物 |
| ES2965352T3 (es) | 2017-05-30 | 2024-04-12 | Bristol Myers Squibb Co | Tratamiento de tumores positivos a gen 3 de activación de linfocitos (LAG-3) |
| CN109752548B (zh) * | 2019-02-01 | 2022-05-06 | 广州金域医学检验中心有限公司 | 评估慢性淋巴细胞白血病预后的组合试剂及系统 |
| EP3934418A4 (en) * | 2019-03-08 | 2023-01-18 | Memorial Sloan Kettering Cancer Center | ADAM17 BINDING MOLECULES AND USES THEREOF |
| CN114599678A (zh) | 2019-08-12 | 2022-06-07 | 希望之城 | Il1rap抗体 |
| KR20230093282A (ko) | 2020-10-23 | 2023-06-27 | 브리스톨-마이어스 스큅 컴퍼니 | 폐암에 대한 lag-3 길항제 요법 |
| CN113461818B (zh) * | 2021-06-30 | 2022-01-21 | 徐州医科大学 | 靶向CD276的全人源抗体scFv、嵌合抗原受体、工程化免疫细胞及其制备方法 |
| IL315487A (en) * | 2022-03-07 | 2024-11-01 | Agenus Inc | ANTI-ILT2 antibodies and their uses |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| WO2003086458A1 (en) * | 2002-04-12 | 2003-10-23 | Medimmune, Inc. | Recombinant anti-interleukin-9 antibodies |
| EP1678195A4 (en) | 2003-10-08 | 2008-04-23 | The Feinstein Inst Medical Res | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CHRONIC LYMPHOCYTIC B-CELL LEUKEMIA |
-
2004
- 2004-10-08 EP EP04794503A patent/EP1678195A4/en not_active Withdrawn
- 2004-10-08 CA CA002541360A patent/CA2541360A1/en not_active Abandoned
- 2004-10-08 WO PCT/US2004/033176 patent/WO2005034733A2/en not_active Ceased
- 2004-10-08 JP JP2006534362A patent/JP2007510622A/ja active Pending
- 2004-10-08 US US10/575,671 patent/US8119340B2/en active Active
- 2004-10-08 AU AU2004279441A patent/AU2004279441B2/en not_active Ceased
-
2012
- 2012-01-20 US US13/354,774 patent/US9745364B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007510622A5 (https=) | ||
| Li et al. | Diffuse large B-cell lymphoma | |
| Ghia et al. | Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci | |
| Ghia et al. | Chronic lymphocytic leukemia | |
| Keerthivasan et al. | β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells | |
| Safarzadeh Kozani et al. | In like a lamb; out like a lion: marching CAR T cells toward enhanced efficacy in B-ALL | |
| Milstein et al. | Monoclonal antibodies and cell surface antigens | |
| JP2009539841A5 (https=) | ||
| CN111148514A (zh) | 与免疫调节剂联合应用于癌症免疫治疗的rar选择性激动剂 | |
| JP2009521909A5 (https=) | ||
| JP2007510622A (ja) | Ｂ細胞慢性リンパ性白血病の診断及び治療のための方法及び組成物 | |
| JP2009505676A5 (https=) | ||
| CN106434552B (zh) | 新型nkt样细胞亚群及其治疗肿瘤的用途 | |
| JP2021535100A (ja) | Ｍ２マクロファージ極性化を調節する方法及び治療におけるその使用 | |
| Atherton et al. | Bite-size introduction to canine hematologic malignancies | |
| Rouaen et al. | Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma | |
| Chan et al. | Visualization of CD4/CD8 T cell commitment | |
| JP2008538173A5 (https=) | ||
| Ikezumi et al. | The role of lymphocytes in the experimental progressive glomerulonephritis | |
| JP2008522162A5 (https=) | ||
| Dang et al. | Cutting edge: regulation of uterine NKT cells by a fetal class I molecule other than CD1 | |
| Feeney et al. | Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas lpr mice | |
| Parrens et al. | Primary digestive Richter's syndrome | |
| Ohnishi et al. | Serum levels of soluble adhesion molecules as prognostic factors for acute liver failure | |
| Anurogo et al. | The art of bioimmunogenomics (BIGs) 5.0 in CAR-T cell therapy for lymphoma management |